Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00594802 · ClinicalTrials.gov registry record
Systemic Reactions to Allergen Immunotherapy Amd Skin Testing
A clinical trial of Systemic Reaction, sponsored by University of South Florida.
- Completed
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT00594802 is a study of Systemic Reaction that has completed, run by University of South Florida. The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00594802, a study of Systemic Reaction, has completed, sponsored by University of South Florida.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
Allergy skin tests and allergen immunotherapy are common procedures for both the diagnosis and treatment of atopic diseases. Allergen immunotherapy has proved to be effective in reducing the symptoms of allergic rhinitis and asthma1-2. Despite its clinical benefit, there is risk of systemic reactions associated with these procedures. The systemic reaction rate to skin testing for aeroallergens is significant lower than the rate of reactions to immunotherapy, but it is not negligible. Lin et al reported only 2 patients who had systemic allergic reactions to skin testing for respiratory allergies in 10,400 patients tested.3 They determined the overall risk of inducing anaphylactic reactions by skin testing to be less than 0.02% and other studies have produced similar results.4-5 The rate of systemic reactions to skin testing is likely underscored. Thompson et. al reported a systemic reaction rate of 6% of patients receiving skin testing.6 It is important to recognize the risk of systemic reactions seeing skin testing is commonly done. It is also imperative to recognize the treatments for these reactions to prevent progression. Hypothesis The systemic reaction rate to allergen immunotherapy and skin testing to aeroallergens is higher than previously reported. Biphasic anaphylactic reactions rarely occur with allergen immunotherapy and skin testing.
Conditions Studied
Study Locations (1)
Florida
- USF - Tampa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2006-08 |
| Est. Completion | 2007-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00594802
The ClinicalTrials.gov registry entry for NCT00594802 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of South Florida, which has 252 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Systemic Reaction appearing as the primary indexed condition, and to 0 interventions.
NCT00594802 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT00594802 about?
NCT00594802 is a clinical study titled "Systemic Reactions to Allergen Immunotherapy Amd Skin Testing". Allergy skin tests and allergen immunotherapy are common procedures for both the diagnosis and treatment of atopic diseases. Allergen immunotherapy has proved to be effective in reducing the symptoms of allergic rhinitis and asthma1-2. Despite its clinical benefit, there is risk of systemic reaction...
What is the current status of trial NCT00594802?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2006-08. Estimated completion is 2007-06.
What conditions does trial NCT00594802 study?
This clinical trial studies the following conditions: Systemic Reaction.
Who is sponsoring clinical trial NCT00594802?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00594802 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.